Navigation Links
New Technique May Improve Early Cervical Cancer Treatment
Date:6/1/2009

Modified hysterectomy method could boost survival, German study shows

MONDAY, June 1 (HealthDay News) -- A new approach to performing radical hysterectomy in early-stage cervical cancer patients reduces the risk of complications, death and local tumor recurrence, a German study shows.

The technique, called total mesometrial resection (TMMR), is a modified version of traditional radical hysterectomy. But this new method employs more accurate, anatomically based resection of the cancer to prevent damage to the pelvic autonomous nervous system and to minimize surgery-related trauma, the University of Leipzig researchers report.

In their study, Dr. Michael Hockel and his colleagues assessed the effectiveness of TMMR without radiotherapy in 212 early-stage cervical cancer patients and found a recurrence-free survival rate of 94 percent and a five-year survival rate of 96 percent. The overall cancer recurrence rate was 5 percent, compared to the 28 percent rate seen in patients who undergo traditional radical hysterectomy.

The study, published online June 1 in The Lancet Oncology, also found that 63 percent of patients had no treatment-related complications, 35 percent had grade 1 complications, and 9 percent had grade 2 complications. There were no grade 3 or 4 complications reported.

The researchers wrote that "TMMR without adjuvant radiation has the potential to improve survival by 15 to 20 percent," and called for further evaluation of TMMR in multi-center controlled trials.

More information

The National Women's Health Information Center has more about cervical cancer.



-- Robert Preidt



SOURCE: The Lancet Oncology, news release, May 31, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. New technique may help detect potential breast cancer spread
2. CorMatrix Cardiovascular to Present on its ECM Technology(TM) at the Annual Advanced Cardiac Techniques in Surgery (ACTS) Symposium in New York, N.Y.
3. Medical Nurse Training, Inc. Announces New Techniques to Achieve Tremendous Savings of Lives and Medical Costs of Over $200 Billion Annually
4. MRI: Imaging technique of choice to exam pregnant patients with possible appendicitis
5. New MR technique may help save women from unnecessary breast biopsies
6. New womens imaging technique allows for a more accurate diagnosis of breast cancer
7. IAEA conference to focus on new techniques in cancer treatment
8. New technique that scrambles light may lead to sharper images, wider views
9. First noninvasive technique to accurately predict mutations in human brain tumors
10. Robot improves suture proficiency more rapidly for surgeons inexperienced in laparoscopic techniques
11. Western Orthopaedics in Denver Blends Innovative Techniques to Provide a Spectrum of Shoulder Care
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Technique May Improve Early Cervical Cancer Treatment
(Date:7/28/2014)... (PRWEB) July 28, 2014 Cuidado Casero ... and hospice, PCO, PCA, and PHC in Texas, New Mexico, ... a sponsor of the North Texas Chapter of PAM’s 2014 ... the Peruvian American Medical Society. The North Texas chapter was ... and other professionals interested in improving medical care for the ...
(Date:7/27/2014)... 2014 Hyaluronic Acid can hold 1,000 ... key to the power of Hyaluronic Serums. , "Hyaluronic ... founder of Sublime Beauty®. "But like collagen, it diminishes ... ours improves skin moisture-retention and radiance." , Hyaluronic ... a healthy and beautiful look. Key Ingredients in the ...
(Date:7/27/2014)... Detroit, MI (PRWEB) July 27, 2014 ... the public with organic ways to achieve a younger ... eye cream buyer's guide to help men and women ... . , The details that are presented in the ... range of price information for consumers. On drawback to ...
(Date:7/27/2014)... new pill-only antiviral drug regimens could provide shorter, more ... majority of patients infected with hepatitis C, even those ... two studies published in The Lancet . , ... is the most common genotype in the USA, Europe, ... the most difficult to treat. , Around 150 million ...
(Date:7/27/2014)... a powerful drug given at the time of a ... of rejection, but that it also allows a less ... the operation. , The key results are reported in ... Transplant Congress in San Francisco today. They will help ... combinations of treatments used to prevent early kidney rejection ...
Breaking Medicine News(10 mins):Health News:Cuidado Casero Sponsors Peruvian American Medical Society (PAMS) Gala 2Health News:Aging or Dry Skin Benefits from Hyaluronic Serum; Now 30% Off Sale at Sublime Beauty® 2Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C 2Health News:The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C 3Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 2Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 3
... Improving communications skills and the use of a simple ... inappropriate prescriptions of antibiotics, a joint Cardiff University trial ... trial, published in the British Medical Journal , ... Medicine together with researchers from the Maastricht University Medical ...
... Tartrate Sublingual Tablet in Treating Middle-of-the-Night Awakening ... in the Treatment of Obsessive Compulsive DisorderRICHMOND, ... (Nasdaq: TSPT ), a specialty ... commercialization of proprietary products that address important ...
... laser-assisted liposuction offers patients better results and quicker ... liposuction systems currently on the market; Now available ... 21 Palomar Medical Technologies, Inc. (Nasdaq: ... of light-based systems for cosmetic treatments, announced today ...
... Inc. (MDLH. PK) ( http://www.mitcanada.ca http://www.mitinvest.ca ), ... the Joint Venture Agreement with its Chinese partners. , ... most recent trip to China having completed the negotiations and ... has also received an initial order of 120 Agro-Jet(R) for ...
... Efficacy Rates in Patients with Challenging Anatomy Consistent ... May 21 New data presented today at ... that Abbott,s market-leading XIENCE V(R) Everolimus Eluting Coronary ... (target lesion revascularization), stent thrombosis and major adverse ...
... sprees to boost emotional well-being in hard times , , ... worries, some women may actually overspend to try to cheer ... 700 women found that 79 percent said they,d go on ... 40 percent listed "depression" and 60 percent listed "feeling a ...
Cached Medicine News:Health News:Blood tests and better communication skills could cut over-prescribing of antibiotics 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 3Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 4Health News:New Clinical Data Shows Significant Improvement in the Appearance of Fat Using SlimLipo(TM) Laser 2Health News:New Clinical Data Shows Significant Improvement in the Appearance of Fat Using SlimLipo(TM) Laser 3Health News:New Clinical Data Shows Significant Improvement in the Appearance of Fat Using SlimLipo(TM) Laser 4Health News:MIT is pleased to announce that it has signed the Joint Venture agreement with its Chinese partners and has received an initial order of 120 units for Animal vaccination 2Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 2Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 3Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 4Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 5Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 6Health News:Shop 'Til You Drop: You May Feel Better 2
(Date:7/27/2014)... 2014 /PRNewswire-iReach/ -- This is a professional ... Chinese Vardenafil (CAS 224785-90-4) industry. The report ... (CAS 224785-90-4) including its classification, application and ... and China,s top manufacturers of Vardenafil (CAS ... value, cost, gross margin and market share ...
(Date:7/25/2014)... 25, 2014  Depomed, Inc. (NASDAQ: DEPO ... fiscal year 2014 financial results after the market closes ... conference call beginning at 4:30 pm EDT, 1:30 pm PDT to ... call by dialing 877-317-6789 ( United States ... be available via a live webcast on the investor ...
(Date:7/25/2014)... July 25, 2014  CVS Caremark Corporation (NYSE: ... on Tuesday, August 5, 2014, at 8:30 a.m. (EDT) ... 2014 financial results. An audio webcast of ... Investor Relations portion of the CVS Caremark website for ... http://info.cvscaremark.com/investors . This webcast will be archived and available ...
Breaking Medicine Technology:Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts 2Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts 3Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts 4Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2
... gamma imaging,(BSGI) is effective in the detection of cancers ... a study presented today at the annual meeting of,the ... "BSGI can identify the most ... Rachel F. Brem, M.D., professor of,radiology and director of ...
... Laboratories, a leading clinical-diagnostics and biomedical-research laboratory specializing ... launched two tests to evaluate the response ... to a primary immunodeficiency disorder, chemotherapy drugs, or because ... a transplant. The company launched the two new assays, ...
Cached Medicine Technology:New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: